Acalabrutinib & Zanubrutinib for Relapsed/Refractory Mantle Cell Lymphoma - Blood Cancers Library GRACE - Global Resource for Advancing Cancer Education 4:40 1 year ago 123 Скачать Далее
Ibrutinib for Relapsed/Refractory Mantle Cell Lymphoma - Blood Cancers Video Library GRACE - Global Resource for Advancing Cancer Education 7:19 1 year ago 67 Скачать Далее
Acalabrutinib Vs Zanubrutinib For Relapsed/Refractory CLL | Adam Kittai, MD | ASCO 2023 HealthTree Foundation for Blood Cancers 5:23 2 months ago 35 Скачать Далее
Dr. Song on Zanubrutinib Activity in Relapsed/Refractory MCL OncLive 1:08 5 years ago 148 Скачать Далее
Relapsed/Refractory Mantle Cell Lymphoma Lymphoma Research Foundation 7:51 1 year ago 963 Скачать Далее
Dr. Tam on Zanubrutinib Vs Ibrutinib Research in Mantle Cell Lymphoma OncLive 1:02 4 years ago 254 Скачать Далее
BTK Inhibitors Improve Responses Relapsed/Refractory Mantle Cell Lymphoma Targeted Oncology 1:33 4 years ago 143 Скачать Далее
Lori Leslie, MD, considers the use of zanubrutinib in relapsed/refractory mantle cell lymphoma OBRoncology 0:47 4 years ago 56 Скачать Далее
ALPINE results: zanubrutinib vs. ibrutinib in CLL VJHemOnc – Video Journal of Hematology & HemOnc 0:47 5 years ago 532 Скачать Далее
Chaitra Ujjani, MD, considers the ideal patient profile for zanubrutinib in RR-MCL OBRoncology 1:05 4 years ago 139 Скачать Далее
Yuqin Song | ASH 18 | Zanubrutinib (BGB-3111) in relapsed/refractory Mantle Cell Lymphoma Lymphoma Hub 2:23 5 years ago 174 Скачать Далее
Debate: Relapsed Mantle Cell Lymphoma - Ibrutinib based Therapy Alone HMP Education 11:45 3 years ago 338 Скачать Далее
Update on Relapsed/Refractory Mantle Cell Lymphoma | LRF Webinars Lymphoma Research Foundation 1:20:06 2 years ago 2 226 Скачать Далее
Relapsed/Refractory B-cell Lymphomas in the CAR-T Era: Improving Outcomes in a Population at Need LurieCancerCenter 50:48 2 years ago 229 Скачать Далее
